Business · 23/05/2002Updated: 10/17/2026 · 1 min read
FDA Clears Ardeparin Sodium Injection for Approval
Summary
The US Food and Drug Administration (FDA) has made a determination that Ardeparin Sodium Injection (Normiflo) was not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of abbreviated new drug applications (ANDAs) for the medication.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →